Gene Query: POMK

Dataset Description Geneva Score
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 18.26
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 18.26
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 16.69
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 15.78
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 15.24
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 14.34
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 13.5
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 13.5
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 11.96
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 11.57
Impact of dieldrin on transcription in Jurkat T cells 9.93
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 9.9
Genome-wide chromatin analysis of Ewing sarcoma 9.09
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 9.09
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 8.66
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 8.49
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 8.49
RNA sequencing of mechanically strained NHEKs and control NHEKs 8.35
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 7.57
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 7.57
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 7.49
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 6.95
RNAseq analysis of ESRP regulated splicing events in prostate cancer 6.92
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 6.85
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 6.85
Systematic discovery of endogenous human ribonucleoprotein complexes 6.76
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 6.76
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 6.76
Identification of transcription start sites for human A549 cell line using ReCappable-seq 6.66
circRNA profile in hypopharyngeal cancer 6.46
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 6.38
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 6.33
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 6.33
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 6.21
A role for ZNF598 in post-transcriptional gene regulation 6.16
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 5.84
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 5.7
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 5.7
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 5.66
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 5.39
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 5.37
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 5.24
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 5.16
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 5.16
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 4.93
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 4.76
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 4.76
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 4.76
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 4.74
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 4.65
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 4.57
Hijacking of stress response machinery by oncogenes in acute leukaemia 4.57
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 4.56
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 4.55
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 4.35
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 4.27
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 4.24
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 4.18
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 4.14
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 3.93
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 3.91
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 3.89
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 3.85
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 3.79
Genome wide miR-191 target profile determined by RIP and gene expression profiling 3.79
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 3.76
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 3.7
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 3.7
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 3.67
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 3.66
Total RNA-seq in ALL-SIL upon JQ1 inhibition 3.65
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 3.65
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 3.54
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 3.41
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 3.39
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 3.39
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 3.31
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 3.28
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 3.28
HNRNPM-regulated splicing dependencies in prostate cancer 3.26
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 3.26
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 3.25
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 3.2
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 3.2
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 3.18
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 3.15
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 3.15
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 3.1
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 3.1
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 3.08
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 3.06
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 2.98
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 2.98
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 2.97
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 2.94
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 2.92
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 2.9
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 2.8
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 2.71
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 2.68
An siRNA screen identifies CHD4 as a target for epigenetic therapy 2.67
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 2.64
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 2.61
Ribosomal protein RPL26 is the principal target of UFMylation 2.59
Glioblastoma stem cells infected by ZIKA virus 2.56
Zika infected neural stem cells 2.54
Transcriptome analysis of Zika infected neural stem cells 2.54
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 2.54
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 2.53
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 2.53
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.52
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 2.5
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 2.45
TGF-β regulation of miRNA expression in pancreatic cancer 2.44
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 2.33
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 2.32
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 2.29
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 2.28
Regulation of poly(A) tail and translation during the somatic cell cycle 2.26
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 2.26
LIN28A modulates splicing and gene expression programs in breast cancer cells 2.26
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 2.26
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 2.23
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 2.23
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 2.21
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 2.21
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 2.18
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 2.18
RNA-seq analysis of control and Myc-induced U2OS cells 2.14
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 2.14
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 2.14
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 2.11
PRDM1 inhibits proliferation of human colon cancer organoids 2.09
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 2.07
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 2.04
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 2.04
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 2.04
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 2.02
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 2.01
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 2.0
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 1.98
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 1.97
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 1.97
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.96
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.96
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 1.93
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 1.93
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 1.91
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 1.91
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 1.9
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 1.9
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 1.9
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 1.89
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 1.89
TAF1 is critical for AE driven leukemogenesis 1.89
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 1.88
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 1.84
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 1.84
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 1.8
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 1.8
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 1.76
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 1.76
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 1.76
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 1.76
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 1.75
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 1.75
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 1.72
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 1.71
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 1.7
Transcriptome of U251 cells overexpression complement component 7 1.69
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 1.64
Gene expression changes after LOC550643 silencing 1.63
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 1.62
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 1.62
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 1.62
1.62
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 1.61
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 1.6
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 1.58
Studying the selectivity of a small molecule Synucleozid on transcriptome 1.58
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 1.56
RNA-seq of YB5 cells treated with Proscillaridin A 1.56
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 1.56
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.55
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 1.55
Differential Gene Expression between MCF10A and MCF7 cells 1.54
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 1.53
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 1.53
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 1.53
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 1.53
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 1.52
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 1.52
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 1.52
MicroRNA-125a-5p overexpression in human macrophages 1.51
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 1.5
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 1.5
Illumina HiSeq Sequencing on Breast cancer PDX samples 1.48
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 1.47
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 1.46
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 1.46
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 1.46
Gene expression analysis upon mtDNA depletion [RNA-seq] 1.46
Gene expression analysis upon mtDNA depletion 1.46
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 1.44
SF3B1 Degron knockdown RNA-seq 1.42
U1 snRNP telescripting regulates size-function stratified human genome 1.42
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 1.41
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 1.41
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 1.4
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 1.39
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 1.39
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 1.39
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 1.38
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 1.38
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 1.37
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 1.36
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 1.36
Ribosomal footprinting of CN34-Parental and CN34-LM1a 1.35
The cohesin complex prevents Myc-induced replication stress 1.35
RNA sequencing analysis of selumetinib-resistant CRC cells lines 1.34
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 1.34
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 1.34
Tracing Enhancer Networks using Epigenetic Traits (TENET) 1.33
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 1.32
Paxillin regulates genomic networks in prostate cancer [C4-2] 1.32
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 1.3
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 1.29
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 1.29
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 1.28
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 1.28
Identification of global XBP1s target gene expression in human prostate cancer cells 1.27
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 1.27
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 1.27
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 1.27
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 1.27
RNA splicing alteration on glioblastoma and normal neural stem cells 1.26
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 1.26
Accurate annotation of human protein-coding small open reading frames 1.26
Ribosomal footprinting of MDA-Parental and MDA-LM2 1.26
Integrin signaling regulates YAP/TAZ to control skin homeostasis 1.26
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  1.24
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 1.2
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 1.2
ML29755 RNA-seq data 1.2
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 1.2
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 1.19
Cajal bodies are linked to genome conformation 1.18
Cajal bodies are linked to genome conformation [RNA-Seq] 1.18
TOP2B disturbed the quality of human oocytes with advanced maternal age 1.18
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 1.17
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 1.16
Epigenome regulation during epidermal lineage commitment [RNA-seq] 1.16
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 1.16
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 1.16
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 1.15
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 1.14
Retinoic acid suppresses MYB in adenoid cystic carcinoma 1.14
mRNA recovered upon RNF219 IP. [RNA-IP] 1.14
Total RNA-seq in ALL-SIL upon TLX1 knockdown 1.13
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 1.13
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 1.12
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 1.11
N6-methyladenine DNA Modification in Glioblastoma 1.09
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 1.09
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 1.09
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 1.09
RNA-seq of cells with TET1 knockout 1.08
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 1.08
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 1.08
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 1.08
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 1.08
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 1.07
ENCODE Cold Spring Harbor Labs Long RNA-seq 1.05
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 1.02
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 1.02
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 1.01
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 1.01
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 1.01
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 1.0
Epigenome regulation during epidermal lineage commitment 1.0
Patient-derived xenograft platform for metastatic melanoma 0.99
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 0.99
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 0.97
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 0.96
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 0.96
FBXW7 modulates stress response by post-translational modification of HSF1 0.96
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 0.95
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 0.95
RNA-seq of SCLC PDX models treated with EP 0.95
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 0.95
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.94
Mapping interactions for the TNIP2 hub protein 0.94
RNA-seq analysis of uveal melanoma cells treated with FR900359 0.93
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 0.93
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 0.93
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 0.93
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 0.93
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 0.92
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 0.92
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 0.91
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 0.91
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 0.9
Loss of CREBBP results in gene expression repression in lymphoma cells 0.9
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 0.89
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 0.88
Dissecting neural differentiation regulatory networks through epigenetic footprinting 0.88
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 0.87
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 0.86
Lysine benzoylation is a novel histone mark 0.86
Lysine benzoylation is a novel histone mark [RNA-seq] 0.86
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.85
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 0.83
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 0.83
Real-time observation of light-controlled transcription in living cells 0.83
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 0.83
Identification of long noncoding RNAs regulated by p53 0.81
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 0.81
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 0.81
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 0.8
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 0.79
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 0.79
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.78
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 0.78
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 0.78
High-throughput sequencing of PROMPT-enriched samples. 0.77
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 0.76
Cellular response to hepatitis E virus (HEV) infection 0.75
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 0.75
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 0.75
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 0.75
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 0.75
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 0.74
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 0.74
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 0.74
RNAseq of Breast cancer PDX samples 0.74
mRNA-sequencing of breast cancer subtypes and normal tissue 0.73
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 0.72
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 0.7
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 0.7
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 0.7
Role for citron kinase in prostate cancer growth 0.69
The cohesin release factor WAPL restricts chromatin loop extension. 0.69
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 0.69
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 0.68
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.67
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 0.66
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 0.65
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.65
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.65
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 0.64
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 0.64
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 0.63
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 0.63
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 0.62
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 0.62
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.61
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.61
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 0.58
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 0.54
Gene expression profile in breast cancer cells 0.54
PNET animal model: new insights (II) 0.52
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 0.52
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 0.52
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 0.52
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 0.52
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.51
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.51
Transposon-based construction of strand-specific RNA-seq libraries 0.5
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 0.48
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.48
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 0.48
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.48
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.48
RNAseq analysis of ruxolitinib treated breast cancers 0.47
Effect of PBK knockdown on C4-2 cell transcriptome 0.47
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 0.47
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 0.44
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 0.44
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.43
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 0.43
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.43
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.43
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 0.43
Transcriptome analysis upon C6orf203 silencing 0.42
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.42
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 0.41
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 0.41
Epigenomic conservation of transposable element silencing [RNA-seq] 0.41
Epigenomic conservation of transposable element silencing 0.41
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 0.4
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 0.4
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.4
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 0.4
Global response to chemotherapy-induced apoptosis 0.39
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.39
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.39
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.38
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 0.38
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.38
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 0.37
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 0.36
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 0.35
The pioneer factor CEBPA modulates vitamin D signaling 0.35
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.35
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 0.35
The MEF2B Regulatory Network - RNA-seq data 0.35
The MEF2B Regulatory Network 0.35
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 0.35
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 0.35
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.34
Identification of long noncoding RNAs in T-ALL cell lines 0.32
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 0.32
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 0.32
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 0.32
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 0.32
Oncogenic roles of ARID5B in T-ALL 0.31
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.31
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 0.31
hESC neural differentiation 0.31
RNA-seq analysis of gene expression patterns during hESC neural differentiation 0.31
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 0.31
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 0.31
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 0.31
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.3
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 0.3
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 0.3
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 0.3
The expression profiles of GBC liver metastasis 0.3
RNA seq_PDX2_SHP099 0.3
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 0.29
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.29
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 0.29
Entrectinib Resistance in a Neuroblastoma Xenograft Model 0.29
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 0.29
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.28
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.28
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 0.28
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 0.28
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.27
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 0.26
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.26
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.26
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 0.26
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 0.24
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.24
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.24
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 0.24
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 0.23
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 0.21
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 0.2
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 0.2
Transcriptional changes in lymphoma cells induced by LSD1 depletion 0.2
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 0.2
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 0.19
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.18
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.18
Global transcriptome analysis of HAP1 cells 0.17
MHC Transcriptomic landscape at haplotype-specific resolution 0.16
p53 activity results in DNA replication fork processivity 0.16
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.16
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 0.16
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 0.15
Positively selected enhancer elements endow tumor cells with metastatic competence 0.15
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.15
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  0.14
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.14
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.12
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 0.12
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 0.11
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 0.11
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 0.11
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 0.1
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 0.1
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 0.1
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 0.09
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 0.09
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.09
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 0.07
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 0.07
Oncogenic MYC induces a dependency on the spliceosome in human cancer 0.07
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.06
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.06
RNA-seq of cancer cell lines treated with T-025 0.05
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.04
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.04
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.03
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.03
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.03
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.03
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.03
Differences in miRNA Detection Levels are Technology and Sequence Dependent 0.02
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 0.02
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 0.02
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 0.02
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.01
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.01
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 0.01
hNSCs siRNA NOVA2 0.01
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.01
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation